Skip to main content
OpenTrials

Clinical trial condition

Non-alcoholic Fatty Liver Disease

Explore clinical trials studying Non-alcoholic Fatty Liver Disease. Study availability and eligibility vary by location and protocol.

1,138 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Non-alcoholic Fatty Liver Disease trial results

Active, Not Recruiting

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

NCT04849728

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +5 more
Locations
  • Objective Health - Birmingham Gastroenterology Associates Birmingham, Alabama, United States
  • Digestive Health Specialist of the Southeast Dothan, Alabama, United States
  • North Alabama GI Research Center llc Madison, Alabama, United States
  • The Institute For Liver Health - Chandler Chandler, Arizona, United States
View all 459 locations
View Trial Details
Active, Not Recruiting

Phase 2b Study of GSK4532990 in Adults With NASH

NCT05583344

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations
  • GSK Investigational Site Homewood, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
View all 170 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

NCT04505436

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • North Alabama GI Research Center Huntsville, Alabama, United States
  • Synexus US - Chandler Chandler, Arizona, United States
  • Precision Research Institute, LLC. (PRI) Chula Vista, California, United States
  • Fresno Clinical Research Center Fresno, California, United States
View all 60 locations
View Trial Details
Active, Not Recruiting

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

NCT04822181

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • North AL Health Res, LLC Huntsville, Alabama, United States
  • The Institute for Liver Health Chandler, Arizona, United States
  • Inst-Liver Hlth dba AZ Liver H Peoria, Arizona, United States
  • Inst. Liver H II dba AZ Liver H Tucson, Arizona, United States
View all 557 locations
View Trial Details
Active, Not Recruiting

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

NCT06151964

Conditions
Body Weight, Body Weight Changes, Diabetes Mellitus, +17 more
Locations
  • Research Site Graz, Austria
  • Research Site Vienna, Austria
  • Research Site Surrey, British Columbia, Canada
  • Research Site Hamilton, Ontario, Canada
View all 15 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

NCT03900429

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • East Valley Family Physicians Chandler, Arizona, United States
  • The Institute for Liver Health - Chandler Chandler, Arizona, United States
  • The Institute for Liver Health - Glendale Glendale, Arizona, United States
View all 247 locations
View Trial Details

Related conditions